New Data in Simultaneous Pancreas-Kidney Transplantation Further Demonstrates the Value of Prospera dd-cf - Benzinga

Biopsy-matched study assesses pancreas rejection in the context of a simultaneous kidney-pancreas transplant AUSTIN, Texas, March 22, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA

Biopsy-matched study assesses pancreas rejection in the context of a simultaneous kidney-pancreas transplant AUSTIN, Texas, March 22, 2022 /PRNewswire/ -- Natera, Inc. NTRA, a global leader in cell-… [+5766 chars]

full article...